Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor

JH Perlman, L Laakkonen, R Osman and MC Gershengorn

Department of Medicine, Cornell University Medical College, New York, New York 10021.

The thyrotropin-releasing hormone (TRH) receptor (TRH-R) is a member of the seven-transmembrane region, G protein-coupled receptor family. Arg- 283 and Arg-306, in transmembrane helices 6 and 7, respectively, are putatively in positions homologous to those of residues that are important for agonist and antagonist binding in receptors for neurotransmitters. These arginines were mutated and the mutant receptors were transiently expressed in COS-1 cells. The affinity of the R306K TRH-R was similar to that of the wild-type (WT) TRH-R, whereas no specific binding was detected in cells expressing R306A, R306E, or R306L TRH-Rs. Because TRH stimulated inositol phosphate (IP) formation to similar maximal extents in cells expressing WT and Arg-306 mutant TRH-Rs, relative potencies were used to estimate the relative affinities of the receptors. The EC50 values for stimulation of R306A, R306E, and R306L TRH-Rs were 1500-, 1200-, and 3000-fold higher than that for the WT TRH-R. No specific binding was measurable in COS-1 cells expressing R283K, R283H, or R283A TRH-Rs, whereas maximal TRH stimulation of IP formation was to levels 64%, 42%, or < 1%, respectively, of that in cells expressing WT TRH-Rs; for R283K and R283H TRH-Rs, EC50 values were 6300- and 50,000-fold higher, respectively, than that for the WT TRH-R. In AtT-20 cells stably expressing R283A TRH-Rs, the binding affinity was 39,000-fold lower than that of the WT TRH-R and the number of receptors was estimated to be 0.88 x 10(6)/cell, but TRH did not stimulate IP formation. Thus, in the TRH-R, Arg-306 appears to be important for binding but not for activation, whereas Arg-283 appears to be important for binding and activation.

Volume 47, Issue 3, pp. 480-484, 03/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				Z.-G. Gao, A. Chen, D. Barak, S.-K. Kim, C. E. Muller, and K. A. Jacobson Identification by Site-directed Mutagenesis of Residues Involved in Ligand Recognition and Activation of the Human A3 Adenosine Receptor J. Biol. Chem., May 17, 2002; 277(21): 19056 - 19063. [Abstract] [Full Text] [PDF]

				M. C. Gershengorn and R. Osman Minireview: Insights into G Protein-Coupled Receptor Function Using Molecular Models Endocrinology, January 1, 2001; 142(1): 2 - 10. [Abstract] [Full Text] [PDF]

				B. F. O’Dowd, D. K. Lee, W. Huang, T. Nguyen, R. Cheng, Y. Liu, B. Wang, M. C. Gershengorn, and S. R. George TRH-R2 Exhibits Similar Binding and Acute Signaling but Distinct Regulation and Anatomic Distribution Compared with TRH-R1 Mol. Endocrinol., January 1, 2000; 14(1): 183 - 193. [Abstract] [Full Text]

				A.-O. Colson, J. H. Perlman, A. Jinsi-Parimoo, D. R. Nussenzveig, R. Osman, and M. C. Gershengorn A Hydrophobic Cluster between Transmembrane Helices 5 and 6 Constrains the Thyrotropin-Releasing Hormone Receptor in an Inactive Conformation Mol. Pharmacol., December 1, 1998; 54(6): 968 - 978. [Abstract] [Full Text]

				Y.-M. Sun, R. P. Millar, H. Ho, M. C. Gershengorn, and N. Illing Cloning and Characterization of the Chicken Thyrotropin-Releasing Hormone Receptor Endocrinology, August 1, 1998; 139(8): 3390 - 3398. [Abstract] [Full Text] [PDF]

				M. Yamada, K. Hashimoto, T. Satoh, N. Shibusawa, H. Kohga, Y. Ozawa, S. Yamada, and M. Mori A Novel Transcript for the Thyrotropin-Releasing Hormone Receptor in Human Pituitary and Pituitary Tumors J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4224 - 4228. [Abstract] [Full Text] [PDF]

				B. L. Roth, M. Shoham, M. S. Choudhary, and N. Khan Identification of Conserved Aromatic Residues Essential for Agonist Binding and Second Messenger Production at 5-Hydroxytryptamine2A Receptors Mol. Pharmacol., August 1, 1997; 52(2): 259 - 266. [Abstract] [Full Text]

				J. H. Perlman, W. Wang, D. R. Nussenzveig, and M. C. Gershengorn A Disulfide Bond between Conserved Extracellular Cysteines in the Thyrotropin-releasing Hormone Receptor Is Critical for Binding J. Biol. Chem., October 20, 1995; 270(42): 24682 - 24685. [Abstract] [Full Text] [PDF]

				H. H. Ho, N. Ganeshalingam, A. Rosenhouse-Dantsker, R. Osman, and M. C. Gershengorn Charged Residues at the Intracellular Boundary of Transmembrane Helices 2 and 3 Independently Affect Constitutive Activity of Kaposi's Sarcoma-associated Herpesvirus G Protein-coupled Receptor J. Biol. Chem., January 5, 2001; 276(2): 1376 - 1382. [Abstract] [Full Text] [PDF]